Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration
暂无分享,去创建一个
D. Centonze | F. Carbone | V. De Rosa | G. Matarese | M. Salvetti | C. La Rocca | A. Uccelli | V. Brescia Morra | G. Orefice | M. Galgani | F. Perna | S. Longobardi | R. Lanzillo | A. Colamatteo | G. Maniscalco | I. Cerillo | C. Florio | A. Visconti | Alessandra Colamatteo | Claudia La Rocca
[1] Changhan Lee,et al. Nutrition and fasting mimicking diets in the prevention and treatment of autoimmune diseases and immunosenescence , 2017, Molecular and Cellular Endocrinology.
[2] J. Powell,et al. Targeting Metabolism as a Novel Therapeutic Approach to Autoimmunity, Inflammation, and Transplantation , 2017, The Journal of Immunology.
[3] F. Issa. Foxp3 and Toll-Like Receptor Signaling Balance Treg Cell Anabolic Metabolism for Suppression , 2017 .
[4] Cody S. Olsen,et al. Distinct effects of obesity and puberty on risk and age at onset of pediatric MS , 2016, Annals of clinical and translational neurology.
[5] M. Warmoes,et al. Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression , 2016, Nature Immunology.
[6] T. Morgan,et al. A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms. , 2016, Cell reports.
[7] T. Olsson,et al. Body mass index during adolescence, rather than childhood, is critical in determining MS risk , 2016, Multiple sclerosis.
[8] N. Timpson,et al. Obesity and Multiple Sclerosis: A Mendelian Randomization Study , 2016, PLoS medicine.
[9] J. Correale,et al. Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis. , 2016, JAMA neurology.
[10] Li Guo,et al. Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice , 2016, Journal of Neuroimmunology.
[11] V. De Rosa,et al. Immunometabolic biomarkers of inflammation in Behçet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens , 2016, Clinical and experimental immunology.
[12] F. Carbone,et al. The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements , 2016, Immunity.
[13] E. Havrdová,et al. The comparison of selected cerebrospinal fluid and serum cytokine levels in patients with multiple sclerosis and normal pressure hydrocephalus. , 2015, Neuro endocrinology letters.
[14] V. De Rosa,et al. Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants , 2015, Nature Immunology.
[15] G. Tedeschi,et al. Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate. , 2015, Metabolism: clinical and experimental.
[16] G. Trianni,et al. Bioenergetics profile of CD4(+) T cells in relapsing remitting multiple sclerosis subjects. , 2015, Journal of biotechnology.
[17] T. Olsson,et al. Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis , 2014, Neurology.
[18] F. Carbone,et al. Corrigendum: Regulatory T cell proliferative potential is impaired in human autoimmune disease , 2014, Nature Medicine.
[19] L. Platanias,et al. Beta Interferon Regulation of Glucose Metabolism Is PI3K/Akt Dependent and Important for Antiviral Activity against Coxsackievirus B3 , 2014, Journal of Virology.
[20] Chih-Hao Chang,et al. Fueling Immunity: Insights into Metabolism and Lymphocyte Function , 2013, Science.
[21] C. Weyand,et al. Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells , 2013, The Journal of experimental medicine.
[22] Å. Lernmark,et al. Meta-Immunological Profiling of Children With Type 1 Diabetes Identifies New Biomarkers to Monitor Disease Progression , 2013, Diabetes.
[23] J. Michálek,et al. Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations , 2012, Journal of the Neurological Sciences.
[24] J. Rathmell,et al. Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.
[25] M. Salmon,et al. The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivo. , 2008, The Journal of clinical investigation.
[26] C. Baecher-Allan,et al. Multiple Sclerosis and Regulatory T Cells , 2008, Journal of Clinical Immunology.
[27] J. Arbiser,et al. Honokiol, a Natural Plant Product, Inhibits Inflammatory Signals and Alleviates Inflammatory Arthritis1 , 2007, The Journal of Immunology.
[28] C. Markowitz. Interferon-beta , 2007, Neurology.
[29] Y. Okuda,et al. The activation of memory CD4+ T cells and CD8+ T cells in patients with multiple sclerosis , 2005, Journal of the Neurological Sciences.
[30] V. De Rosa,et al. Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[31] L. Hofbauer,et al. Osteoprotegerin is highly expressed in the spinal cord and cerebrospinal fluid , 2004, Acta Neuropathologica.
[32] J. Kratzsch,et al. The soluble leptin receptor is crucial for leptin action: evidence from clinical and experimental data , 2003, International Journal of Obesity.
[33] C. Brosnan,et al. Peroxisome proliferator‐activated receptor‐γ agonists prevent experimental autoimmune encephalomyelitis , 2002 .
[34] S. Cummings,et al. Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. , 2001, The Journal of clinical endocrinology and metabolism.
[35] J. Hillert,et al. Systemic upregulation of CD40 and CD40 ligand mRNA expression in multiple sclerosis , 2000, Multiple sclerosis.
[36] D. Lacey,et al. Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.
[37] A. Aruffo,et al. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[38] A. Akbar,et al. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. , 2006, The Journal of clinical investigation.
[39] C. Brosnan,et al. Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis. , 2002, Annals of neurology.
[40] A. Compston,et al. Multiple sclerosis. , 2002, Lancet.